EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy.
|
27989324 |
2017 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy.
|
27989324 |
2017 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy.
|
27989324 |
2017 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Paraganglioma
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.
|
30008476 |
2018 |
Paraganglioma
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
ACC = adrenal cortical carcinoma; APA = aldosterone-producing adenoma; APCC = aldosterone-producing cell cluster; CAH = congenital adrenal hyperplasia; CT = computed tomography; DOTATATE = [<sup>68</sup>Ga]-DOTA(0)-Tyr(3)-octreotate; FDG = fluorodeoxyglucose; FH = fumarate hydratase; MR = miner-alocorticoid; MDH2 = malate dehydrogenase 2; PCC = pheochromocytoma; PET = positron emission tomography; PGL = paraganglioma; SCS = subclinical cortisol-secreting; SDHB = succinate dehydrogenase subunit B; TCGA = The Cancer Genome Atlas.
|
28332880 |
2017 |
Paraganglioma
|
0.340 |
Biomarker
|
disease |
BEFREE |
Disruption of the Krebs cycle is a hallmark of cancer, and MDH2 has been recently identified as a novel pheochromocytoma and paraganglioma susceptibility gene.
|
27989324 |
2017 |
Paraganglioma
|
0.340 |
Biomarker
|
disease |
BEFREE |
Segregation of the mutation with disease and absence of MDH2 in mutated tumors revealed MDH2 as a novel pheochromocytoma/paraganglioma susceptibility gene.
|
25766404 |
2015 |
Paraganglioma
|
0.340 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Carcinoma, Ovarian Epithelial
|
0.300 |
Biomarker
|
disease |
CTD_human |
In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.
|
28811376 |
2017 |
Hereditary Paraganglioma-Pheochromocytoma Syndrome
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.
|
25766404 |
2015 |
Congestive heart failure
|
0.300 |
Biomarker
|
disease |
RGD |
Adriamycin induced myocardial failure in rats: protective role of Centella asiatica.
|
16786185 |
2007 |
Carcinoma
|
0.300 |
Biomarker
|
group |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Animal Mammary Neoplasms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Mammary Neoplasms, Experimental
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Anaplastic carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Carcinoma, Spindle-Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Undifferentiated carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Carcinomatosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Mammary Carcinoma, Animal
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Congestive heart failure
|
0.300 |
Biomarker
|
disease |
HPO |
|
|
|
peptidylamidoglycolate lyase activity
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
|
|
|
Myocardial Infarction
|
0.210 |
Biomarker
|
disease |
BEFREE |
NBP treatment significantly reduced the infarct ratio, as observed by TTC staining, decreased serum myocardial enzymes in MI, and restored heart mitochondrial enzymes (isocitrate dehydrogenase (ICDH), succinate dehydrogenase (SDH), malate dehydrogenase (MDH), and a-ketoglutarate dehydrogenase (a-KGDH) activities after MI.
|
28619102 |
2017 |
Myocardial Infarction
|
0.210 |
Biomarker
|
disease |
RGD |
Effect of alpha-tocopherol on mitochondrial electron transport in experimental myocardial infarction in rats.
|
9753871 |
1998 |